van Dam, MA;
Bijlstra, OD;
Faber, RA;
Warmerdam, MI;
Achiam, MP;
Boni, L;
Cahill, RA;
... Mieog, JSD; + view all
(2024)
Consensus conference statement on fluorescence-guided surgery (FGS) ESSO course on fluorescence-guided surgery.
European Journal of Surgical Oncology
, 50
(2)
, Article 107317. 10.1016/j.ejso.2023.107317.
Preview |
PDF
1-s2.0-S0748798323009551-main.pdf - Published Version Download (13MB) | Preview |
Abstract
Background: Fluorescence-guided surgery (FGS) has emerged as an innovative technique with promising applications in various surgical specialties. However, clinical implementation is hampered by limited availability of evidence-based reference work supporting the translation towards standard-of-care use in surgical practice. Therefore, we developed a consensus statement on current applications of FGS. Methods: During an international FGS course, participants anonymously voted on 36 statements. Consensus was defined as agreement ≥70% with participation grade of ≥80%. All participants of the questionnaire were stratified for user and handling experience within five domains of applicability (lymphatics & lymph node imaging; tissue perfusion; biliary anatomy and urinary tracts; tumor imaging in colorectal, HPB, and endocrine surgery, and quantification and (tumor-) targeted imaging). Results were pooled to determine consensus for each statement within the respective sections based on the degree of agreement. Results: In total 43/52 (81%) course participants were eligible as voting members for consensus, comprising the expert panel (n = 12) and trained users (n = 31). Consensus was achieved in 17 out of 36 (45%) statements with highest level of agreement for application of FGS in tissue perfusion and biliary/urinary tract visualization (71% and 67%, respectively) and lowest within the tumor imaging section (0%). Conclusions: FGS is currently established for tissue perfusion and vital structure imaging. Lymphatics & lymph node imaging in breast cancer and melanoma are evolving, and tumor tissue imaging holds promise in early-phase trials. Quantification and (tumor-)targeted imaging are advancing toward clinical validation. Additional research is needed for tumor imaging due to a lack of consensus.
Type: | Article |
---|---|
Title: | Consensus conference statement on fluorescence-guided surgery (FGS) ESSO course on fluorescence-guided surgery |
Location: | England |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1016/j.ejso.2023.107317 |
Publisher version: | http://dx.doi.org/10.1016/j.ejso.2023.107317 |
Language: | English |
Additional information: | This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third-party material in this article are included in the Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
Keywords: | Conference consensus statement, Fluorescence, Fluorescence-guided surgery, Imaging, Indocyanine green, Humans, Female, Fluorescence, Surgery, Computer-Assisted, Breast Neoplasms, Lymph Nodes, Specialties, Surgical |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci > Department of Targeted Intervention |
URI: | https://discovery-pp.ucl.ac.uk/id/eprint/10190431 |
Archive Staff Only
![]() |
View Item |